Skip to search formSkip to main contentSkip to account menu

SMND 309

Known as: SMND-309, SMND309 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
In silico Designing and Optimization of EPO Mimetic Using Combinatorial Library
Erythrpoitin receptor (EPOR) is a cytokine receptor protein, which on activation by binding to erythropoietin (EPO), triggers the… 
Highly Cited
2013
Highly Cited
2013
SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway.
2012
2012
Protective effect of SMND-309 on CCl_4-induced hepatotoxicity in mice
To investigate the protective effects of SMND-309 on CCl4 induced hepatotoxicity in mice and the possible mechanisms involved in… 
2011
2011
Therapeutic effects of SMND-309, a new metabolite of salvianolic acid B, on experimental liver fibrosis.
2011
2011
Study on antioxidant activities of SMND-309
The antioxidant activities of SMND-309 were investigated using different analysises including 1,1-diphenyl-2-picrylhydrazyl(DPPH… 
2011
2011
Neuroprotective Effects of SMND-309 on Apoptosis Induced by Oxygen-Glucose Deprivation in SH-SY5Y Cells
The human neuroblastoma SH-SY5Y were cultured in a hypoxia/hypoglyc-emia condition to induce cell apoptosis in vitro.The… 
2009
2009
Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in rats.
(2E)-2-{6-[(E)-2-carboxyvinyl]-2,3-dihydroxyphenyl}-3-(3,4-dihydroxyphenyl) propenoic acid, a novel compound designated SMND-309… 
2009
2009
SMND-309, a novel derivate of salvianolic acid B, attenuates apoptosis and ameliorates mitochondrial energy metabolism in rat cortical neurons.
SMND-309, a novel compound (2E)-2-[6-[(E)-2-carboxyvinyl]-2,3-dihydroxyphenyl]-3-(3,4-dihydroxyphenyl) acrylic acid, is a new… 
2009
2009
SMND-309, a novel derivate of salvianolic acid B, ameliorates cerebral infarction in rats: Characterization and role
2009
2009
Protections of SMND-309, a novel derivate of salvianolic acid B, on brain mitochondria contribute to injury amelioration in cerebral ischemia rats.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)